Paul-Xavier is a highly skilled senior executive with more than 20 years of industry experience in the biotechnology and pharmaceutical industry including roles with Sanofi Pasteur, Medicago, and GlaxoSmithKline. He is experienced in process development, technology transfer, green fields, production in cGMP and GLP environments, and Lean Six Sigma project management standards. Paul-Xavier has led multidisciplinary teams as well as large and complex projects from research and development to commercialization. Over his career, Paul-Xavier has contributed to the commercialization of over a billion doses of vaccines and in recent years was at the forefront of the COVID-19 crisis with Medicago and Inventprise. Paul-Xavier’s passion for developing individuals to enhance their performance and deliver safe medicines to patients was applied in his role with projects in collaboration with the prestigious Bill and Melinda Gates Foundation. Over the span of his career, he successfully helped drive change and implement new processes internationally. He was an influencer at Sanofi Pasteur Canada to introduce Industry 4.0 in a major capital project.